Advanced search
Publication Cover
Emerging Microbes & Infections Volume 6, 2017 - Issue 1
Submit an article Journal homepage
979
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Differences in sequences between HBV-relaxed circular DNA and covalently closed circular DNA

Magda RybickaDepartment of Molecular Diagnostics, Intercollegiate Faculty of BiotechnologyUniversity of Gdansk and Medical University of Gdansk, Abrahama 58, Gdansk80-307, Poland
,
Anna WoziwodzkaDepartment of Molecular Diagnostics, Intercollegiate Faculty of BiotechnologyUniversity of Gdansk and Medical University of Gdansk, Abrahama 58, Gdansk80-307, Poland
,
Tomasz RomanowskiDepartment of Molecular Diagnostics, Intercollegiate Faculty of BiotechnologyUniversity of Gdansk and Medical University of Gdansk, Abrahama 58, Gdansk80-307, Poland
,
Piotr StalkeDepartment of Infectious DiseasesMedical University of Gdansk, Smoluchowskiego 18, Gdansk80-214, Poland
,
Marcin DręczewskiDepartment of Molecular Diagnostics, Intercollegiate Faculty of BiotechnologyUniversity of Gdansk and Medical University of Gdansk, Abrahama 58, Gdansk80-307, Poland
&
Krzysztof Piotr BielawskiDepartment of Molecular Diagnostics, Intercollegiate Faculty of BiotechnologyUniversity of Gdansk and Medical University of Gdansk, Abrahama 58, Gdansk80-307, PolandCorrespondence[email protected]
Pages 1-7 | Received 13 Dec 2016, Accepted 09 Apr 2017, Published online: 15 Jan 2019

References

  • Chemin I, Zoulim F.Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett 2009;286: 52–59.
  • Trépo C, Chan HLY, Lok A.Hepatitis B virus infection. Lancet 2014;384: 2053–2063.
  • Baumert TF, Verrier ER, Nassal Met al.Host-targeting agents for treatment of hepatitis B virus infection. Curr Opin Virol 2015;14: 41–46.
  • Zoulim F, Locarnini S.Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance. Liver Int 2013;33 : 116–124.
  • Nassal M.HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 2015;64: 1972–1984.
  • Seeger C, Mason WS.HBV replication, pathobiology and therapy: unanswered questions. J Hepatol 2016;64: S1–S3.
  • Zoulim F, Locarnini S.Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 2009;137: 1593–608-2.
  • Chevaliez S, Hézode C, Bahrami Set al.Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely. J Hepatol 2013;58: 676–683.
  • Domingo E, Sheldon J, Perales C.Viral quasispecies evolution. Microbiol Mol Biol Rev 2012;76: 159–216.
  • Rybicka M, Stalke P, Dreczewski Met al.High-throughput matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative approach to monitoring drug resistance of hepatitis B virus. J Clin Microbiol 2014;52: 9–14.
  • Rybicka M, Stalke P, Bielawski KP.Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS. Clin Microbiol Infect 2015;21: 288.e1–4.
  • Ikawa H, Hayashi Y, Ninomiya Tet al.Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon. Hum Pathol 2001;32: 910–917.
  • Margeridon S, Carrouée-Durantel S, Chemin Iet al.Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA. Antimicrob Agents Chemother 2008;52: 3068–3073.
  • Luan J, Yuan J, Li Xet al.Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry. Clin Chem 2009;55: 1503–1509.
  • Liu Y, Hussain M, Wong Set al.A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA. J Clin Microbiol 2007;45: 553–558.
  • Zoulim F.Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection. Antiviral Res 2004;64: 1–15.
  • Locarnini S, Zoulim F.Molecular genetics of HBV infection. Antivir Ther 2010;15: 3–14.
  • Margeridon-Thermet S, Svarovskaia ES, Babrzadeh Fet al.Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of lamivudine treatment. Antimicrob Agents Chemother 2013;57: 343–349.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.